FGFR: Proof-of-concept study of AZD4547 in patients with FGFR1 or FGFR2 amplified tumours.

被引：0
|
作者：
Smyth, Elizabeth Catherine
Turner, Nicholas C.
Popat, Sanjay
Morgan, Shethah
Owen, Kate
Gillbanks, Angela
Jain, Vikram Kumar
Cunningham, David
机构：
[1] Royal Marsden Hosp NHS Fdn Trust, London, England
[2] AstraZeneca, Macclesfield, Cheshire, England
[3] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2626
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II multicenter proof of concept study of AZD4547 in FGFR amplified tumours.
    Smyth, Elizabeth Catherine
    Turner, Nicholas C.
    Peckitt, Clare
    Pearson, Alex
    Brown, Gina
    Chua, Sue
    Gillbanks, Angela
    Johnston, Stephen R. D.
    Tarazona, Noelia
    Cutts, Ros
    Kilgour, Elaine
    Rooney, Claire
    Smith, Neil R.
    Sumpter, Katherine Anne
    Ajaz, Mazhar A.
    Thomas, Anne L.
    Watkins, David
    Chau, Ian
    Popat, Sanjay
    Cunningham, David
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] FGFR2 Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547
    Xie, Liang
    Su, Xinying
    Zhang, Lin
    Yin, Xiaolu
    Tang, Lili
    Zhang, Xiuhua
    Xu, Yanping
    Gao, Zeren
    Liu, Kunji
    Zhou, Minhua
    Gao, Beirong
    Shen, Danping
    Zhang, Lianhai
    Ji, Jiafu
    Gavine, Paul R.
    Zhang, Jingchuan
    Kilgour, Elaine
    Zhang, Xiaolin
    Ji, Qunsheng
    CLINICAL CANCER RESEARCH, 2013, 19 (09) : 2572 - 2583
  • [3] Structural Insights into FGFR Kinase Isoform Selectivity: Diverse Binding Modes of AZD4547 and Ponatinib in Complex with FGFR1 and FGFR4
    Tucker, Julie A.
    Klein, Tobias
    Breed, Jason
    Breeze, Alexander L.
    Overman, Ross
    Phillips, Chris
    Norman, Richard A.
    STRUCTURE, 2014, 22 (12) : 1764 - 1774
  • [4] FGFR1 and FGFR2 in fibrolamellar carcinoma
    Graham, Rondell P.
    Garcia, Joaquin J.
    Greipp, Patricia T.
    Fritcher, Emily G. Barr
    Kipp, Benjamin R.
    Torbenson, Michael S.
    HISTOPATHOLOGY, 2016, 68 (05) : 686 - 692
  • [5] Inactivation of fgfr1 and fgfr2 in Postnatal Astrocytes
    Rubin, L. B.
    Smith, K.
    INTEGRATIVE AND COMPARATIVE BIOLOGY, 2017, 57 : E392 - E392
  • [6] FGFR1 and FGFR2 Mutations in Pfeiffer Syndrome
    Chokdeemboon, Chayanin
    Mahatumarat, Charan
    Rojvachiranonda, Nond
    Tongkobpetch, Siraprapa
    Suphapeetiporn, Kanya
    Shotelersuk, Vorasuk
    JOURNAL OF CRANIOFACIAL SURGERY, 2013, 24 (01) : 150 - 152
  • [7] Mechanisms of Efficacy of the FGFR1–3 Inhibitor AZD4547 in Pediatric Solid Tumor Models
    Nikki Phanhthilath
    Sara Hakim
    Catherine Su
    Andrea Liu
    Divya Subramonian
    Jacqueline Lesperance
    Peter E. Zage
    Investigational New Drugs, 2020, 38 : 1677 - 1686
  • [8] Phase II study of AZD4547 in FGFR amplified tumours: gastroesophageal cancer (GC) cohort clinical and translational results
    Smyth, E. C.
    Turner, N.
    Pearson, A.
    Peckitt, C.
    Chau, I.
    Watkins, D.
    Kilgour, E.
    Smith, N. R.
    Gillbanks, A.
    Chua, S.
    Brown, G.
    Cutts, R.
    Rooney, C.
    Llavero, N. Tarazona
    Thomas, A.
    Popat, S.
    Cunningham, D.
    ANNALS OF ONCOLOGY, 2015, 26 : 44 - 44
  • [9] Phase II study of AZD4547 in FGFR amplified tumours: Gastroesophageal cancer (GC) cohort pharmacodynamic and biomarker results.
    Smyth, Elizabeth Catherine
    Turner, Nicholas C.
    Pearson, Alex
    Peckitt, Clare
    Chau, Ian
    Watkins, David J.
    Starling, Naureen
    Rao, Sheela
    Gillbanks, Angela
    Kilgour, Elaine
    Sumpter, Katherine Anne
    Smith, Neil R.
    Cutts, Ros
    Rooney, Claire
    Thomas, Anne L.
    Ajaz, Mazhar A.
    Chua, Sue
    Brown, Gina
    Popat, Sanjay
    Cunningham, David
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [10] The resistance mechanism of FGFR2 amplified gastric cancer cells against AZD4547, a fibroblast growth factor receptor inhibitor
    Lee, S. Y.
    Jeong, Y.
    Na, Y.
    Kim, J. L.
    Lee, D. H.
    Oh, S. C.
    ANNALS OF ONCOLOGY, 2016, 27
12345